SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001385508-20-000108
Filing Date
2020-11-12
Accepted
2020-11-12 16:26:10
Documents
69
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q opnt-20200930.htm   iXBRL 10-Q 1007907
2 EX-31.1 exhibit31109302020.htm EX-31.1 12181
3 EX-31.2 exhibit31209302020.htm EX-31.2 12107
4 EX-32.1 exhibit32109302020.htm EX-32.1 5619
5 EX-32.2 exhibit32209302020.htm EX-32.2 5543
  Complete submission text file 0001385508-20-000108.txt   4896777

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT opnt-20200930.xsd EX-101.SCH 41035
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT opnt-20200930_cal.xml EX-101.CAL 62824
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT opnt-20200930_def.xml EX-101.DEF 217923
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT opnt-20200930_lab.xml EX-101.LAB 459855
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT opnt-20200930_pre.xml EX-101.PRE 348874
11 EXTRACTED XBRL INSTANCE DOCUMENT opnt-20200930_htm.xml XML 665266
Mailing Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401
Business Address 201 SANTA MONICA BOULEVARD SUITE 500 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38193 | Film No.: 201307122
SIC: 1000 Metal Mining